Maternal exposure to bisphenol A induces fetal growth restriction via upregulating the expression of estrogen receptors.

[1]  Ling Ma,et al.  Mixed‐lineage leukaemia 1 contributes to endometrial stromal cells progesterone responsiveness during decidualization , 2020, Journal of cellular and molecular medicine.

[2]  W. Xue,et al.  BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis. , 2020, Environmental pollution.

[3]  G. Song,et al.  A mechanism for the effect of endocrine disrupting chemicals on placentation. , 2019, Chemosphere.

[4]  B. Huppertz,et al.  Human trophoblast invasion: new and unexpected routes and functions , 2018, Histochemistry and Cell Biology.

[5]  Nasir Jalal,et al.  Bisphenol A (BPA) the mighty and the mutagenic , 2017, Toxicology reports.

[6]  Qi Li,et al.  Low concentration of BPA induces mice spermatocytes apoptosis via GPR30 , 2017, Oncotarget.

[7]  P. Myllynen,et al.  The xenoestrogens, bisphenol A and para-nonylphenol, decrease the expression of the ABCG2 transporter protein in human term placental explant cultures , 2016, Molecular and Cellular Endocrinology.

[8]  B. An,et al.  Interaction of steroid receptor coactivators and estrogen receptors in the human placenta. , 2016, Journal of molecular endocrinology.

[9]  K. Dahlman-Wright,et al.  Estrogen receptor alpha and beta in health and disease. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[10]  A. Rutkowska,et al.  Health risk of exposure to Bisphenol A (BPA). , 2015, Roczniki Panstwowego Zakladu Higieny.

[11]  Jan-Gowth Chang,et al.  Demethylation within the proximal promoter region of human estrogen receptor alpha gene correlates with its enhanced expression: Implications for female bias in lupus. , 2014, Molecular immunology.

[12]  J. Gustafsson,et al.  The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified , 2014, Proceedings of the National Academy of Sciences.

[13]  J. Unadkat,et al.  Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update , 2014, The AAPS Journal.

[14]  A. Piersma,et al.  Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  J. Rochester.  Bisphenol A and human health: a review of the literature. , 2013, Reproductive toxicology.

[16]  V. Jordan,et al.  Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells , 2013, British journal of pharmacology.

[17]  S. Marchitti,et al.  Human and rat ABC transporter efflux of bisphenol a and bisphenol a glucuronide: interspecies comparison and implications for pharmacokinetic assessment. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  I. Crocker,et al.  Placental Apoptosis in Health and Disease , 2010, American journal of reproductive immunology.

[19]  M. Marino,et al.  Bisphenol A impairs estradiol‐induced protective effects against DLD‐1 colon cancer cell growth , 2010, IUBMB life.

[20]  C. Mendelson,et al.  Estrogen Receptor (cid:1) (ER (cid:1) ) Mediates Stimulatory Effects of Estrogen on Aromatase ( CYP19 ) Gene Expression in Human Placenta , 2009 .

[21]  L. Altucci,et al.  Laccase treatment impairs bisphenol A‐induced cancer cell proliferation affecting estrogen receptor α‐dependent rapid signals , 2008, IUBMB life.

[22]  A. Buzdar.  Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer. , 2008, Drugs of today.

[23]  S. Brennecke,et al.  The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  R. Santen,et al.  Demethylation of promoter C region of estrogen receptor α gene is correlated with its enhanced expression in estrogen-ablation resistant MCF-7 cells , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  H. Kroemer,et al.  Organic Anion Transporting Polypeptide 2B1 and Breast Cancer Resistance Protein Interact in the Transepithelial Transport of Steroid Sulfates in Human Placenta , 2007, Drug Metabolism and Disposition.

[26]  Shu-yun Liu,et al.  [Expression and localization of estrogen receptor ERalpha and the kinds of ERbeta mRNA on placenta]. , 2006, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[27]  Yi Zhang,et al.  Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. , 2006, American journal of physiology. Endocrinology and metabolism.

[28]  A. Buzdar,et al.  Fulvestrant: a new type of estrogen receptor antagonist for the treatment of advanced breast cancer. , 2004, Drugs of today.

[29]  R. Pazdur,et al.  FDA drug approval summaries: fulvestrant. , 2002, The oncologist.

[30]  C. Jones,et al.  Trophoblast differentiation during formation of anchoring villi in a model of the early human placenta in vitro. , 1995, Placenta.

[31]  E. Dodds,et al.  Synthetic Œstrogenic Agents without the Phenanthrene Nucleus , 1936, Nature.